Ramsay Health Care Ltd (ASX: RHC) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Ramsay Health Care Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.55 billion
P/E Ratio 44.44
Dividend Yield 2.08%
Shares Outstanding 228.88 million
Earnings per share 1.634
Dividend per share 1.52
Year To Date Return 2.31%
Earnings Yield 2.25%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Ramsay Health Care Ltd (ASX: RHC)
Latest News

A person leans over to whisper a secret to a colleague during a meeting.
Broker Notes

UBS warns of more downgrades for ASX 200 shares… but not all

If now isn't the time to be buying the dip, then when?

Read more »

A telehealth doctor at her desk.
Healthcare Shares

Why is the Ramsay share price smashing the ASX 200 on Monday?

Ramsay shares are off to a positive start today.

Read more »

Female doctor with a mask holds out hand in a stop gesture.
Healthcare Shares

Ramsay Health Care share price on watch amid Bupa contract termination

Ramsay is playing hardball with Bupa...

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

These were the best performing ASX 200 shares in April

These ASX 200 shares were on form in April...

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Share Market News

ASX 200 midday update: ResMed disappoints, PointsBet rockets higher

The ASX 200 is having a good day...

Read more »

A health professional sits contemplating in the corridor of a hospital.
Earnings Results

Ramsay Health share price bleeds as profits plunge

COVID-19 continues to be an expensive disruptor for the hospital giant in Q3...

Read more »

A man clenches his fists with glee having seen the Lake Resources share price go up on the computer screen in front of him.
Share Gainers

These were the best performing ASX 200 shares last week

These ASX 200 shares were on fire last week...

Read more »

Top 10 asx shares today
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Friday.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
05 Sep 2017 $0.8150 100.00% Final 28 Sep 2017
07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
04 Sep 2015 $0.6050 100.00% 24 Sep 2015
05 Mar 2015 $0.4050 100.00% 26 Mar 2015
08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009

RHC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Ramsay Health Care Ltd

Ramsay Health Care Limited (RHC) is a global healthcare company that operates 221 hospitals and 14 day surgery centres, treatment facilities, rehabilitation and psychiatric units and a nursing college across Australia, United Kingdom, France, Indonesia, Malaysia and Italy.

Established in Sydney, Australia, in 1964, Ramsay Health Care has more than 50 years of experience in providing acute health care services. RHC made its ASX debut in 1997 and the Ramsay share price has gone from strength to strength since.

Today, Ramsay employs more than 77,000 staff and delivers a range of acute and primary healthcare services from 480 facilities across 11 countries, making it one of the largest and most diverse private healthcare companies in the world.

RHC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
04 Jul 2022 $72.67 $-0.33 -0.45% 389,810 $74.49 $74.67 $72.67
01 Jul 2022 $73.00 $-0.24 -0.33% 383,859 $73.32 $74.16 $73.00
30 Jun 2022 $73.24 $0.00 0.00% 474,688 $73.18 $73.79 $72.99
29 Jun 2022 $73.24 $-0.31 -0.42% 535,185 $72.04 $73.62 $72.04
28 Jun 2022 $73.55 $-0.09 -0.12% 326,361 $74.00 $74.00 $73.19
27 Jun 2022 $73.64 $2.12 2.96% 271,674 $71.80 $73.99 $71.80
24 Jun 2022 $71.52 $0.39 0.55% 516,694 $71.10 $71.52 $69.93
23 Jun 2022 $71.13 $-0.14 -0.20% 405,736 $72.14 $72.14 $70.95
22 Jun 2022 $71.27 $-0.26 -0.36% 394,120 $71.57 $72.52 $71.21
21 Jun 2022 $71.53 $0.12 0.17% 417,016 $71.42 $72.07 $71.07
20 Jun 2022 $71.41 $0.60 0.85% 647,058 $70.95 $71.75 $70.46
17 Jun 2022 $70.81 $-2.32 -3.17% 1,287,772 $72.24 $72.56 $70.69
16 Jun 2022 $73.13 $-1.01 -1.36% 825,893 $75.40 $75.40 $72.74
15 Jun 2022 $74.14 $-0.64 -0.86% 814,461 $75.00 $75.20 $73.71
14 Jun 2022 $74.78 $-2.69 -3.47% 859,050 $75.00 $75.36 $73.83
10 Jun 2022 $77.47 $0.00 0.00% 561,394 $77.64 $78.04 $77.42
09 Jun 2022 $77.47 $0.49 0.64% 783,092 $77.86 $78.25 $77.27
08 Jun 2022 $76.98 $1.21 1.60% 431,577 $75.64 $77.37 $75.57
07 Jun 2022 $75.77 $-1.02 -1.33% 465,938 $76.13 $76.55 $75.23

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
29 Apr 2022 Karen Penrose Exercise 580 $39,996
Conversion of securities.
29 Apr 2022 Karen Penrose Issued 580 $39,996
Conversion of securities. average price, VWAP
15 Dec 2021 Craig McNally Issued 57 $3,951,765
Issue of securities. 163,736 - Performance Rights
03 Sep 2021 Karen Penrose Issued 580 $39,996
Employee Share Ownership Plan/Directors Salary Sacrifice. 580 - Share Rights
Average price/VWAP
31 Aug 2021 Craig McNally Expiry 90 $6,223,392
As advised by the company. 106,046 - Performance Rights
90,325 Performance Rights granted under the Executive Performance Rights Plan failed to vest and therefore lapsed on 31 August 2021.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Peter John Evans Non-Executive DirectorNon-Executive Deputy Chairman Dec 1990
Mr Evans began working with Ramsay Health Care in 1969. He is a Chartered Accountant who was in public practice for over 20 years with predecessor firms of KPMG. Mr Evans has specialised in the financial management of hospitals and has had experience in the health care field for 50 years. Mr Evans is also a Trustee of the Paul Ramsay Foundation. He is Chair of the Risk committee.
Mr David Ingle Thodey Non-Executive Director Nov 2017
Mr Thodey is a business leader who has had a executive career in the technology and telecommunications industries, with more than 30 years of experience creating brand and shareholder value. In addition to being a Non-Executive Director and Lead Independent Director of Ramsay Health Care, Mr Thodey is currently Chairman of Australia's national scientific research agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Chairman of Tyro Payments Limited (a leading alternative payments provider) and Xero Limited (a small business accounting software company). Mr Thodey also had a successful career as CEO of Telstra, Australia's leading telecommunications and information services company, and prior to that he was CEO of IBM. Mr Thodey was awarded an Order of Australia in 2017 for his service to business and the promotion of ethical leadership and workplace diversity. In the past three years, Mr Thodey has served as a Director of the following listed companies: Xero Limited (Appointed June 2019), Tyro Payments Limited (Appointed November 2018) and Vodafone Group Plc (Resigned July 2020). He is chairman of Governance Committee and member of People Committee.
Ms Catriona Alison Deans Non-Executive Director Nov 2018
Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. She is also Chair of Cochlear Limited and a Non-Executive Director of SCEGGS Darlinghurst and Deputy Pty Ltd. She is also on the Investment Committee of MainSequence Ventures.
In her executive career, Ms Deans was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited, (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas and, most recently, CEO of netus Pty Ltd - a technology investment company acquired by Fairfax. Ms Deans also spent seven years as a Consultant with McKinsey & Company and is currently a Senior Advisor with the firm. She is chair of the people committee.
Mr Michael Stanley Siddle Non-Executive DirectorNon-Executive Chairman May 1975
Mr Siddle has experience in the management of private hospitals and has been integrally involved in Ramsay Health Care's successful expansion through construction, mergers and acquisitions. He is also a Director of the Paul Ramsay Foundation He is a member of the People and Governance committee.
Mr Craig Ralph McNally Chief Executive OfficerManaging Director Jul 2017
Mr McNally has worked across operational, strategic and financial roles. Mr McNally is also the Chairman of Ramsay Sante.
Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
Ms Penrose has had an executive career in leadership and CFO roles, mainly in financial services. She has worked in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. In addition to being a Non-Executive Director of Ramsay Health Care, Ms Penrose also serves as a Director of Vicinity Centres, Bank of Queensland and Estia Health. Ms Penrose is a member of Chief Executive Women and on the Board of Marshall Investments Pty Limited and Rugby Australia Limited. She is a member of the Risk management committee.
Mr Steven Andrew Sargent Non-Executive Director Nov 2021
Mr Sargent has international executive experience including 22 years at General Electric where he led businesses across a range of industries including healthcare, energy and financial services across the USA, Europe and Asia. Mr Sargent has been serving as a non-executive director on several boards since 2015 and is currently a Non-Executive Director of Origin Energy Limited and Deputy Chairman and Lead Independent Director of infection prevention company Nanosonics Limited. He is also currently a Non-Executive Director and Chairman of OFX Group Limited. His unlisted board activities include Chairman of The Origin Energy Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.
Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
Dr Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and was transferred to the USA focusing on supporting health care companies, including pharmaceutical/ medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Sussmuth Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She also led McKinsey's Asia-wide Health Systems and Services Sector. Dr Dyckerhoff also supports start-ups in the health care area; she joined the board of the Health Tech company HUMA in April 2021 and the board of QuEST Global in November 2020. She is a member of the Risk management committee.
Mr James Malcolm McMurdo Non-Executive Director Sep 2019
Mr McMurdo has over 30 years finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked in both the Asia Pacific and European regions.Mr McMurdo is one of the Founding Partners of Privatus Capital Partners, an advisory and merchant banking business focussed on private capital. Prior to establishing Privatus, Mr McMurdo held senior management roles at Deutsche Bank and was based in Hong Kong. During his time at Deutsche Bank, he was Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand. He sat on the firm's Global Executive Committee for the Corporate and Investment Bank for four years. Prior to this, Mr McMurdo was a Partner at Goldman Sachs, where he held senior positions in the Investment Banking Division in Australia and Europe.
Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
Mr Martyn Roberts Chief Financial Officer
Dr Robert Herkes Chief Medical Officer
Henrietta Rowe Company SecretaryGroup General Counsel

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 51,594,147 22.54%
Paul Ramsay Holdings Pty Limited 42,999,269 18.78%
J P Morgan Nominees Australia Pty Limited 30,788,535 13.45%
Citicorp Nominees Pty Limited 15,714,365 6.86%
National Nominees Limited 7,228,641 3.15%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 4,986,109 2.17%
Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,750,000 1.63%
BNP Paribas Noms Pty Ltd <Drp> 2,943,857 1.28%
Custodial Services Limited <Beneficiaries Holding A/C> 2,759,174 1.20%
Argo Investments Limited 2,023,131 0.88%
Cs Third Nominees Pty Limited < HSBC Cust Nom Au Ltd 13 A/C> 1,949,041 0.85%
Australian Foundation Investment Company Limited 1,915,000 0.83%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> 1,126,284 0.49%
Certane CT Pty Ltd 1,083,948 0.47%
Netwealth Investments Limited <Wrap Services A/C> 1,062,130 0.46%
HSBC Custody Nominees (Australia) Limited (i) 1,052,692 0.46%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 883,811 0.38%
Mutual Trust Pty Ltd 769,053 0.33%
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 638,713 0.27%
BNP Paribas Noms (Nz) Ltd <Drp> 538,278 0.23%